{"id":80746,"date":"2025-03-07T14:34:43","date_gmt":"2025-03-07T12:34:43","guid":{"rendered":"https:\/\/infois.ro\/?p=80746"},"modified":"2025-03-07T14:34:43","modified_gmt":"2025-03-07T12:34:43","slug":"antibiotice-iasi-a-primit-vizita-vicepresedintelui-ibm-research-jason-silbergleit-oportunitati-pentru-inovatie-in-industria-farmaceutica-romaneasca","status":"publish","type":"post","link":"http:\/\/infois.ro\/?p=80746","title":{"rendered":"Antibiotice Ia\u0219i a primit vizita vicepre\u0219edintelui IBM Research, Jason Silbergleit. Oportunit\u0103\u021bi pentru inova\u021bie \u00een industria farmaceutic\u0103 rom\u00e2neasc\u0103"},"content":{"rendered":"

\"\"<\/p>\n

Pe 6 martie, Antibiotice a g\u0103zduit vizita Vicepre\u0219edintelui IBM Research (SUA), Jason Silbergleit, \u0219i a delega\u021biei IBM, \u00een cadrul unei \u00eent\u00e2lniri dedicate integr\u0103rii celor mai noi tehnologii, precum quantum computing \u0219i inteligen\u021ba artificial\u0103, \u00een viitorul Centru de Cercetare-Dezvoltare al Antibiotice Ia\u0219i, Inova a+.<\/p>\n

Vizita a avut loc \u00een contextul lans\u0103rii la Ia\u0219i a unui campus de cercetare, educa\u021bie \u0219i inovare \u00een calcul cuantic, \u00een parteneriat cu compania american\u0103 IBM. Acesta este primul de acest tip din Rom\u00e2nia \u0219i are ca scop transformarea ora\u0219ului Ia\u0219i \u00eentr-un pol regional de cercetare \u00een domeniul tehnologiilor cuantice.<\/p>\n

Cu aceast\u0103 ocazie, Vicepre\u0219edintele IBM Research s-a \u00eent\u00e2lnit cu Ioan Nani, directorul general al Antibiotice Ia\u0219i, Gianina Macovei, director executiv Cercetare-Dezvoltare, \u0218tefania Alexandru, director Planificare strategic\u0103 \u0219i Managementul portofoliului, \u0219i o echip\u0103 de tineri speciali\u0219ti din domeniile cercet\u0103rii \u0219i IT.\"\"<\/p>\n

Discu\u021biile purtate au fost axate pe integrarea quantum computing-ului, inteligen\u021bei artificiale \u0219i altor tehnologii emergente \u00een structura Inova a+. Acest centru ultramodern al Antibiotice, care va beneficia de finan\u021bare european\u0103 pentru produc\u021bia de medicamente critice de la Ministerul Investi\u021biilor \u0219i Proiectelor Europene, va deveni un pilon strategic \u00een dezvoltarea de solu\u021bii terapeutice inovative. Inova a+ va utiliza aceste tehnologii pentru a crea un sistem digitalizat, care va facilita descoperirea rapid\u0103 a medicamentelor \u0219i va \u00eembun\u0103t\u0103\u021bi eficien\u021ba procesului de testare \u0219i validare.<\/p>\n

\u201eParteneriatele strategice cu lideri globali precum IBM sunt esen\u021biale pentru viitorul Antibiotice Ia\u0219i. Prin integrarea tehnologiilor de v\u00e2rf, ne propunem s\u0103 acceler\u0103m descoperirea de medicamente inovative \u0219i s\u0103 optimiz\u0103m procesele de produc\u021bie, men\u021bin\u00e2ndu-ne astfel \u00een topul industriei farmaceutice. Oportunitatea de a colabora cu IBM va \u00eent\u0103ri capacitatea noastr\u0103 de a dezvolta solu\u021bii terapeutice avansate \u0219i va contribui la formarea unui ecosistem de inova\u021bie sustenabil, \u00een cadrul unui parteneriat viabil \u00eentre industrie, mediul academic \u0219i sectorul tehnologic\u201d<\/em>, a declarat Ioan Nani, director general Antibiotice Ia\u0219i.<\/p>\n

\"\"<\/p>\n

Parteneriat strategic cu IBM pentru transformarea digital\u0103 a Antibiotice Ia\u0219i<\/strong><\/p>\n

\u00cen 2024, Antibiotice Ia\u0219i a \u00eencheiat un parteneriat cu corpora\u021bia IBM pentru a adopta solu\u021bia digital\u0103 SAP S\/4HANA, cel mai avansat software de planificare a resurselor (ERP), care integreaz\u0103 toate procesele unei companii. Adoptarea acestei solu\u021bii digitale va \u00eembun\u0103t\u0103\u021bi eficien\u021ba opera\u021bional\u0103 a proceselor digitalizate, va accelera viteza de reac\u021bie a companiei \u0219i va sprijini r\u0103spunsul eficient la nevoile pie\u021bei, \u00een concordan\u021b\u0103 cu principiile dezvolt\u0103rii sustenabile.<\/p>\n

\n","protected":false},"excerpt":{"rendered":"

Pe 6 martie, Antibiotice a g\u0103zduit vizita Vicepre\u0219edintelui IBM Research (SUA), Jason Silbergleit, \u0219i a… more »<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":80747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,41],"tags":[74,1591,40,18025,9951,8218],"aioseo_notices":[],"_links":{"self":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/80746"}],"collection":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=80746"}],"version-history":[{"count":1,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/80746\/revisions"}],"predecessor-version":[{"id":80750,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/80746\/revisions\/80750"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/media\/80747"}],"wp:attachment":[{"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=80746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=80746"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=80746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}